Ex vivo Assays in MM Primary Patient Samples

Vivia Biotech can identify the best drugs for MM patient enhancing your MM drug profiling processes thanks to our improved and novel assays and to the access to biological samples from real patients...

AML Assays in Primary Patient Samples

Vivia Biotech can significantly enhance AML drug profiling processes thanks to our access to biological samples from real patients...

CDx Clinical Trials

An Innovative Biomarker‑Driven Design to Select Patient Population Upfront

T Cell Engagers in Primary Patient Samples

Hematotoxicity and Selectivity Assays

Primary Patient Samples for Hematology-Oncology Research

Proliferation Assays in Hematological Patient Samples

3D TME-Aligned Assays for Small Molecule Immunotherapies

3D TME-Aligned Assays for Immune Check Point Inhibitors (IChP), Mono and Multispecific

TME-aligned 3D Solid Tumor Models for Bispecific Antibodies

Innovative Drug Interaction Studies

Therapeutic window assays for NK-engagers: Killing activity tumor cells vs progenitors

Complement-Dependent Cytotoxicity (CDC) ex vivo Activity Assays at Physiological Levels

Vivia Experts in NK-Engager ex vivo Assays

Discovery Assay to Select Best Bispecific Antibodies Formats

T-Cell Therapy: Activated T Cells (CART and TILs) show killing activity against tumoral cells

TME-Aligned Model: Immuno-Oncology 3D Tumor Cell Killing by T-Cells Assay

more about resources

Click Here